7
Jul
2021
Watch
European Medicines Agency (continuation of debate)
Madam President, Commissioner, a year ago we adopted a resolution on the European Union's public health strategy after the pandemic, in which we all called for a stronger role for the EMA. I think we have managed to adopt a fairly balanced text on the committee, despite all the disputes, which will strengthen the Agency. Therefore, I would like to ask you not to vote against the compromises reached in the ENVI Committee. Unfortunately, I see one huge problem in the current developments surrounding the building of the Health Union. This is a lack of funding for the further development and strengthening of the EMA and ECDC health agencies. It was already clear from the Commission's initial proposal that more money would have to be sent to them, because the current funds would simply be far from sufficient. What was my shock when I found out that, on the contrary, cuts were planned for EMA and ECDC in the planned budget for next year. Yes, some might argue that they will receive some extra money from the EU4Health programme. It can strengthen the funding of these agencies, but at its core it is only project and time-limited funding. Moreover, the programme has far more important priorities that we have overlooked for decades. In addition, so far, it seems that the agencies' regular budget has been cut by exactly as much as they should have received extra. So we just moved the money from the right pocket to the left pocket and we'll expect something to change. So what do we want? I thought we should learn from the current pandemic and strengthen the structures we have. So far, however, it seems that we rather want to maintain the status quo. Colleagues, I very much hope that we will be able to resolve the issue of new funding by the autumn, because if not, then we can blow the whistle on the entire famous Health Union.